FINDEX Inc.

3649

JP3801450002

Advanced Medical Equipment & Technology

Delayed Japan Exchange Other stock markets 10:23:05 2024-05-15 pm EDT			5-day change	1st Jan Change
1,035 ^JPY	-3.27%		+0.10%	+0.49%

Apr. 15	Findex Disposes 10,855 Shares Worth 11 Million Yen as Restricted Stock Compensation	MT
Mar. 28	Findex to Allot Treasury Shares Worth 12 Million Yen to Directors, Executive Officers	MT

FINDEX Inc.'s Equity Buyback announced on July 30, 2018 has expired with 676,000 shares for ¥499.95 million.

September 19, 2018

The company expired its plan on September 20, 2018.

Latest news about FINDEX Inc.

Findex Disposes 10,855 Shares Worth 11 Million Yen as Restricted Stock Compensation	Apr. 14	MT
Findex to Allot Treasury Shares Worth 12 Million Yen to Directors, Executive Officers	Mar. 28	MT
FINDEX Inc. Provides Dividend Guidance for the Second Quarter Ending June 30, 2024	Feb. 13	CI
FINDEX Inc. Provides Dividend Guidance for the Full Year Ending December 31, 2024	Feb. 13	CI
FINDEX Inc. Provides Earnings Guidance for the Six Months Ending June 30, 2024, and for the Full Year Ending December 31, 2024	Feb. 13	CI
FINDEX Inc. Announces Year-End Dividend for the Fiscal Year Ended December 31, 2023, Payable on March 28, 2024	Feb. 13	CI
Findex Inc. Declares Dividend for the Second Quarter Ending December 31, 2023, and Provides Dividend Guidance for the Full Year Ending December 31, 2023	Nov. 13	CI
Incannex Healthcare to Hold Sale Deal Meetings Next Month	23-10-06	MT
Findex Completes Payment of Restricted Stock Compensation	23-05-12	MT
FINDEX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
FINDEX Inc. Provides Dividend Guidance for the Second Quarter Ending June 30, 2023, and for the Full Year Ending December 31, 2023	23-05-11	CI
FINDEX Inc. Provides Earnings Guidance for the Six Months Ending June 30, 2023, and for the Full Year Ending December 31, 2023	23-05-11	CI
Findex to Pay Restricted Stock Compensation	23-04-17	MT
FINDEX Inc. Provides Consolidated and Non-Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2023	23-02-13	CI
FINDEX Inc. Announces Year-End Dividend for the Fiscal Year Ended December 31, 2022, Payable on March 29, 2023; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending December 31, 2023	23-02-13	CI
Findex Reports Growth in Active Users of Health Tech Products	23-01-20	MT
Findex Adds Two Departments to Organizational Structure	23-01-17	MT
FINDEX Inc. Announces Establishment of New Departments	23-01-16	CI
FINDEX Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	22-11-10	CI
FINDEX Inc. Provides Dividend Guidance for the Year Ending December 31, 2022	22-11-10	CI
FINDEX Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	22-08-09	CI
FINDEX Inc. Announces Cash Dividend for the Second Quarter of the Year Ending December 31, 2022, Payable on September 9,2022; Provides Cash Dividend Guidance for the Year Ending December 31, 2022	22-08-09	CI
FINDEX Inc. Revises Consolidated and Non-Consolidated Earnings Guidance for the Six Months of the Fiscal Year Ending December 31, 2022	22-05-18	CI
FINDEX Inc. Provides Earnings Guidance for the First Half and Full Year Ending December 31, 2022	22-05-12	CI
FINDEX Inc. Provides Second Quarter and Year End Dividend Guidance for the Year Ending December 31, 2022	22-05-12	CI

Findex Inc is a Japan-based company mainly engaged in the operation of system development business and health tech business. The Company operates in two business segments. The System Development segment conducts medical system development, medical data integration and analysis, and development of office systems. The Health Tech segment includes medical consulting management consulting, healthcare, data science and artificial intelligence (AI) business. In the medical information systems, medical systems and medical network systems are considered to contribute to all patients by reducing the burden of information management at medical institutions, improving the efficiency of medical institution management and the quality of medical practice. The products include solutions for hospitals and solutions for clinics.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
FINDEX INC.	+0.49%	168M
VEEVA SYSTEMS INC.	+9.80%	32.94B
PRO MEDICUS LIMITED	+24.92%	7.83B
SECTRA AB	+36.69%	4.26B
EVOLENT HEALTH, INC.	-28.70%	2.74B
OMNICELL, INC.	-20.62%	1.39B
VERADIGM INC.	-28.50%	1.27B
LUNIT INC.	-32.48%	1.17B
SIMULATIONS PLUS, INC.	+12.29%	988M
B-SOFT CO.,LTD.	-37.86%	884M

Medical Software & Technology Services

FINDEX Inc.

Equities

3649

JP3801450002

Advanced Medical Equipment & Technology

FINDEX Inc.'s Equity Buyback announced on July 30, 2018 has expired with 676,000 shares for ¥499.95 million.

Latest news about FINDEX Inc.

Chart FINDEX Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Medical Software & Technology Services